External Funding Opportunities
We invite you to peruse the following list of funding opportunities that may be of interest to injury prevention researchers. This information is abstracted for brevity; please refer to the sponsor’s website for complete information.
To add other opportunities to this list, please email us.
In addition, we often publicize funding opportunities via our mailing list. Please become a member to join our mailing list and receive updated information.
OPIOID AND OVERDOSE
- HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional) (Closing Date for Applications: Mar 20, 2024)
- HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R33 Clinical Trial Optional) (Closing Date for Applications: Mar 20, 2024)
- HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K23 – Clinical Trial Required) (Closing Date for Applications: Nov 12, 2025)
- HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K01 – Clinical Trial Required) (Closing Date for Applications: Nov 12, 2025)
- HEAL Initiative- New Innovator Award (DP2 Clinical Trial Not Allowed) (Expiration Date: May 23, 2023)
- HEAL Initiative: Translational Science Career Enhancement Awards for Early and Mid-career Investigators (Expiration Date: May 2, 2023)
- Special Emphasis Notice (SEN): AHRQ Announces Interest in Health Services Research to Address Substance Use Disorder Epidemic (Application Due Date: March 15, 2023)
- Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01 Clinical Trial Optional) (Application Due Dates: July 19, 2022; November 15, 2022; July 19, 2023; November 15, 2023 – each letter of intent due 30 days prior)
- Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R34 Clinical Trial Optional) (Expiration Date: November 16, 2023)
- Cannabis, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (Expiration Date: September 08, 2023)
- Stimulants and HIV: Addressing Contemporary and Recurring Epidemics (R61/R33 – Clinical Trial Required) (Application Due Date: November 12, 2024)
SUICIDE
- Understanding Suicide Risk and Protective Factors among Black Youth (R01 Clinical Trial Not Allowed) (Closing Date for Applications: Jun 20, 2023)
- Understanding Suicide Risk and Protective Factors among Black Youth (R21 Clinical Trial Not Allowed) (Closing Date for Applications: Jun 20, 2023)
- Using Secondary Data Analysis to Determine Whether Preventive Interventions Implemented Earlier in Life Reduce Suicide Risk (U01 Clinical Trial Not Allowed) (Closing Date for Applications: October 10, 2023)
VIOLENCE
- Notice of Special Interest (NOSI): Research on Addressing Violence to Improve Health Outcomes.
- Forecast: Creating Safer States by Advancing Health Equity, Injury, and Violence Prevention (Estimated Application Due Date: Apr 17, 2023)
- Forecast: Advancing Violence Epidemiology in Real-Time (AVERT) (Estimated Application Due Date: May 16, 2023)
CONCUSSION/ TBI
- Coming soon
OLDER ADULT FALLS
- Coming soon
MOTOR VEHICLE CRASH
- Coming soon
ACEs & OTHER EMERGING AREAS
- Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional) (Closing Date for Applications: May 07, 2024)
- AHRQ Health Services Research Demonstration and Dissemination Grants (R18) (Expiration Date: October 1, 2023)
- AHRQ Small Research Grant Program (R03) (Expiration Date: July 08, 2023)
- AHRQ Health Services Research Projects (R01) (Expiration Date: July 08, 2023)
- Occupational Safety and Health Research (R01) (Expiration Date: November 17, 2023)
- Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 – Clinical Trial Optional) (Expiration Date: May 08, 2024)
- Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional) (Application Due Dates: October 18, 2022, February 17, 2023, June 19, 2023, October 17, 2023)
- Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional) (Application Due Dates: October 18, 2022, February 17, 2023, June 19, 2023, October 17, 2023)
- NIOSH Exploratory/Developmental Grant Program (R21) (Expiration Date: November 18, 2023)
- NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional) (Expiration Date: November 16, 2023)
- Notice of Special Interest (NOSI): Research on Co-morbid Substance Use, Substance Use Disorders, and Other Psychiatric Disorders (Expiration Date: May 8, 2023)
- Substance Use/Substance Use Disorder Dissertation Research Award (R36 – Clinical Trials Optional) (Expiration Date: May 08, 2023)
- Advancing Research on SUD through Computational Neuroscience (Expiration Date: September 8, 2023)
- Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) (Expiration Date: September 08, 2023)